We grant clinicians a straightforward way to exploit know-how and hardware to access cutting-edge analysis solutions for quantitative imaging in their routine clinical practice. Thanks to a more informed clinical evaluation, DORIAN hopes to ensure a more prompt and accurate diagnosis, as well as a more pin-pointed patient monitoring. Our prime target is Alzheimer's Disease.
DORIAN is a SaaS, with two patented analysis methods.